Company Filing History:
Years Active: 2005-2013
Title: Mathivanan Packiarajan: Innovator in Pharmaceutical Chemistry
Introduction
Mathivanan Packiarajan is a notable inventor based in Saddle Brook, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work primarily focuses on developing innovative compounds for treating various medical conditions.
Latest Patents
Among his latest patents, Mathivanan has developed 2-substituted-ethynylthiazole derivatives and their uses. This invention provides a range of derivatives that can be utilized in pharmaceutical compositions and methods. Another significant patent involves the use of GAL3 antagonists for the treatment of depression and/or anxiety. This invention includes pyrimidine and indolone derivatives that act as selective antagonists for the GAL3 receptor. The patent outlines methods for creating pharmaceutical compositions that effectively treat depression and anxiety in subjects.
Career Highlights
Mathivanan has worked with prominent companies in the pharmaceutical industry, including H. Lundbeck A/S. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Mathivanan has collaborated with esteemed colleagues such as Thomas P. Blackburn and Michael J. Konkel. These partnerships have further enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Mathivanan Packiarajan is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations in treating mental health conditions. His contributions continue to impact the industry positively.